{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/21/3349079/0/is/alvotech-kynnir-samning-vi%C3%B0-lotus-pharmaceutical-um-marka%C3%B0ssetningu-%C3%A1-fyrirhugu%C3%B0um-hli%C3%B0st%C3%A6%C3%B0um-vi%C3%B0-durvalumab-og-emicizumab-%C3%AD-bandar%C3%ADkjunum-og-%C3%A1-v%C3%B6ldum-m%C3%B6rku%C3%B0um-%C3%AD-as%C3%ADu.html", "message": "News view counter 896585 successfully enlarged"}